Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesNo recent work listed

Michael D. Arensman

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5043473106. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper

Papers 3

  1. Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-15-0204↗
  2. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth. Co-author DOI 10.1158/1535-7163.mct-13-1005↗
  3. HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma. First author DOI 10.1002/cncr.27725↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David W. Dawson · 3 shared papers, 2013–2015 · strength 0.13
  2. Timothy R. Donahue · 2 shared papers, 2013–2014 · strength 0.09
  3. Mara H. Sherman · 1 shared paper, 2015 · strength 0.05
  4. Ronald M. Evans · 1 shared paper, 2015 · strength 0.05
  5. Anne Kovochich · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.